Thymic Stromal Lymphopoietin Blocker class drugs

1 result

Tezspire (tezepelumab-ekko)

(tezepelumab-ekko)
Amgen, Inc
Usage: TEZSPIRE is indicated for the add-on maintenance treatment of severe asthma in adults and pediatric patients aged 12 years and older. It is not intended for the relief of acute bronchospasm or status asthmaticus.